Valvular heart disease, pulmonary hypertension, and fenfluramine/phentermine use

C. J. Bruce, H. M. Connolly

Research output: Contribution to journalReview article

Abstract

Recent findings leading to the reported association of fenfluramine and phentermine use with valvular abnormalities and pulmonary hypertension are discussed. The authors provide current American Heart Association and United States Department of Health and Human Services guidelines for the evaluation and treatment of patients exposed to these agents.

Original languageEnglish (US)
Pages (from-to)17-19
Number of pages3
JournalCardiology Review
Volume15
Issue number11
StatePublished - Dec 1 1998

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Valvular heart disease, pulmonary hypertension, and fenfluramine/phentermine use'. Together they form a unique fingerprint.

  • Cite this